Allied-Market-Research-mobile

Coming Up With New Logo

Cart
0
Get 20% Free Customization In This Report

IVF Devices and Consumables Market by Instrument (Incubators, Cryosystem, Imaging System, Cabinet, Ovum Aspiration Pump, Sperm Separation System, Micromanipulator, Accessories and Disposables, and Others), by Reagent & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, and Embryo Culture Media), by Technique (Fresh Embryo Transfer Technique, Frozen Embryo Transfer Technique, and Donor Egg IVF Technique), and by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2023

  • ID: LI 17124
  • Sep 2017
  • 226 pages
  • Price: $4296
$2765

IVF Devices and Consumables Market Overview:

Global IVF Devices and Consumables Market was valued at $1,506 million in 2016, and is estimated to reach at $4,972 million by 2023, registering a CAGR of 18.3% from 2017 to 2023. In-vitro fertilization (IVF) can be defined as a complex series of procedures utilized to treat genetic and fertility issues and assist with conception. It is the most efficient assisted reproductive technology (ART), helping couples or single parents around the world.

IVF procedure is performed in a clinical laboratory where the matured egg (self-egg or donor’s egg) is fertilized with the sperm (self-sperm or donor’s sperm). The fertilized egg or embryo is then implanted into the uterus. Though IVF does not always give successful results and its success rate varies from individual to individual, it has emerged as a preferable choice for fertility treatments in the clinical industry
Surge in prevalence of delayed pregnancies and growth in infertility rates drive the market. In addition, availability of latest medical technologies in IVF devices throughout the world, is expected to fuel the market growth.

The IVF devices and consumables industry is segmented based on instrument, reagents & media, technology, end user, and geography. Based on instrument, the market is divided into incubators, cryosystem, imaging system, cabinet, ovum aspiration pump, sperm separation system, micromanipulator, accessories and disposables, and others. By reagents & media, the market is classified into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. On the basis of technique, the market is categorized into fresh embryo transfer technique, frozen embryo transfer technique and donor egg IVF technique. By end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market is expected to witness a moderate growth during the forecast period, owing to the rise in adoption of IVF devices and consumables due to surge in disposable income of population. Furthermore, health insurance portability and rise in advertising and marketing of medical facilities to promote IVF devices and consumables are anticipated to augment the market growth. However, costs associated with IVF treatment and reimbursement issues related to fresh IVF cycles are expected to hamper the market growth.

The report provides extensive competitive analysis and profiles of key market players, such as Cook Medical, Inc., Cooper Companies, Inc., Genea Biomedx, JXTG Holdings, Inc., Merck KGAA, Ovascience, Inc., Oxford Gene Technology, Progyny, Inc., Thermo Fisher Scientific, Inc., and Vitrolife AB. The other players in the value chain include GlaxoSmithKline PLC (Viiv Healthcare Group of Companies), AbbVie Inc., Bristol-Myers Squibb Company, and AstraZeneca plc.

Asia-Pacific possesses high potential for the market growth, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. The region is anticipated to experience rapid market growth due to economic development.

Key Benefits:

  • This report entails a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

IVF Devices and Consumables Market Key Segments:

By Instrument

  • Incubators
    • Cryosystem
    • Imaging System
    • Cabinet
    • Ovum Aspiration Pump
    • Sperm Separation System
    • Micromanipulator
    • Accessories and Disposables
    • Others

By Reagents & Media

  • Cryopreservation Media
  • Semen Processing Media
  • Ovum Processing Media
  • Embryo Culture Media

By Technique

  • Fresh Embryo Transfer Technique
  • Frozen Embryo Transfer Technique
  • Donor Egg IVF Technique

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
      • Brazil
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. ALTERNATIVE TECHNOLOGIES

3.2.1. Intrauterine insemination (IUI) technique

3.2.1.1. Factors assessed for the procedure
3.2.1.2. Benefits of this technique
3.2.1.3. Risks

3.2.2. Difference between IUI and IVF technique
3.2.3. GIFT technique

3.2.3.1. Difference between GIFT and IVF technique

3.2.4. ZIFT technique

3.2.4.1. Differences between ZIFT and IVF technique

3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES

3.3.1. Female infertility treatments

3.3.1.1. Limitations of fertility drugs

3.3.2. Male infertility treatments

3.4. COSTS RELATED TO IVF PROCEDURES
3.5. ROLE OF DONORS IN THE IVF MARKET

3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research

3.6. SURROGACY

3.6.1. Legal issues

3.7. IVF TRENDS IN SAME SEX COUPLES

3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In-vitro fertilization

3.8. ADVANCED IVF TECHNOLOGIES

3.8.1. Capsule IVF
3.8.2. Three parent IVF

3.8.2.1. Ethical concerns

3.8.3. Mini IVF

3.8.3.1. Advantages
3.8.3.2. Drawbacks

3.8.4. Embryo Scope

3.8.4.1. Advantages

3.8.5. PICSI

3.9. FERTILITY TREATMENT AND GENDER SELECTION

3.9.1. Methods of sex selection

3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)
3.9.1.4. Ethical and legal issues

3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
3.11. APPLICATION OF STEM CELLS IN IVF
3.12. IVF AND RESOURCE POOR COUNTRIES
3.13. KEY FINDINGS

3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies

3.14. PORTER’S FIVE FORCES ANALYSIS

3.14.1. High competition and large number reduces the power of suppliers
3.14.2. Scattered nature and large count of end users moderates the buyer power
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes

3.15. VALUE CHAIN ANALYSIS
3.16. PATENT ANALYSIS

3.16.1. Patent analysis by year
3.16.2. Patents analysis by country

3.17. REGULATORY ISSUES AND LEGISLATIONS
3.18. INSURANCE REIMBURSEMENT SCENARIO
3.19. CLINICAL TRIALS

3.19.1. Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2. Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3. Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4. Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5. Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures

3.20. DRIVERS

3.20.1. Delayed pregnancies in women
3.20.2. Rise in global infertility rates
3.20.3. Advancement in technology
3.20.4. Rise in gamete donations
3.20.5. Rise in disposable income
3.20.6. Increase in success rates

3.21. RESTRAINTS

3.21.1. Cost constraints
3.21.2. Ethical and legal issues
3.21.3. Multiple pregnancies
3.21.4. Low awareness level

3.22. OPPORTUNITIES

3.22.1. Fertility tourism
3.22.2. Growing number of fertility clinics
3.22.3. Rise in same sex marriages

Chapter: 4 IVF DEVICES MARKET, BY INSTRUMENTS

4.1. GLOBAL IVF MARKET BY INSTRUMENTS TYPES, 2014-2023, ($MILLION)

4.1.1. Incubators

4.1.1.1. Global IVF incubators market by region

4.1.2. Cryosystem

4.1.2.1. Global IVF cryosystem market by Region

4.1.3. Imaging system

4.1.3.1. Global IVF Imaging system market by Region

4.1.4. Cabinet (work station)

4.1.4.1. Global IVF cabinets market by Region

4.1.5. Ovum aspiration pump

4.1.5.1. Global IVF ovum aspiration pump market by Region

4.1.6. Sperm separation system

4.1.6.1. Global IVF sperm separation system market by Region

4.1.7. Micro Manipulator System

4.1.7.1. Global IVF Micromanipulator market by Region

4.1.8. Others

4.1.8.1. Global IVF other instruments market by Region

4.2. ACCESSORIES AND DISPOSABLES

4.2.1. Semen analysis chamber
4.2.2. Plastic ware
4.2.3. Oocyte retrieval needles
4.2.4. Miscellaneous disposables
4.2.5. Global IVF accessories and disposables market by region

Chapter: 5 IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA

5.1. GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023, ($MILLION)
5.2. CRYOPRESERVATION MEDIA

5.2.1. Embryo cryopreservation media
5.2.2. Sperm cryopreservation media
5.2.3. Oocyte cryopreservation media
5.2.4. Global IVF cryopreservation media market by region

5.3. SEMEN PROCESSING MEDIA

5.3.1. Global IVF semen processing media market by region

5.4. OVUM PROCESSING MEDIA

5.4.1. Global IVF ovum processing media market by region

5.5. EMBRYO CULTURE MEDIA

5.5.1. Global IVF embryo culture media market by region

Chapter: 6 IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE

6.1. GLOBAL IVF MARKET, BY TECHNIQUE, 2014-2023 ($MILLION)
6.2. FRESH EMBRYO TRANSFER TECHNIQUE

6.2.1. Drivers

6.2.1.1. Trends of delayed pregnancies
6.2.1.2. Growing rates of infertility

6.2.2. Restraints

6.2.2.1. Cost involved in the treatment
6.2.2.2. Reimbursements issues with fresh embryo ivf cycles

6.2.3. Global fresh embryo IVF cycle market, by region

6.3. FROZEN EMBRYO TRANSFER TECHNIQUE (FER)

6.3.1. Reasons to use this technique
6.3.2. Advantages of Frozen egg IVF technique
6.3.3. Disadvantages of frozen egg IVF technique
6.3.4. Global frozen egg IVF cycle market, by region

6.4. DONOR EGG IVF TECHNIQUE

6.4.1. Benefits of donor egg IVF technique
6.4.2. Risks associated with donor egg IVF cycle technique
6.4.3. Global donor egg IVF cycle market by region

Chapter: 7 IVF DEVICES AND CONSUMABLES MARKET BY END USERS

7.1. GLOBAL IVF MARKET BY END USERS, 2014-2023 ($MILLION)
7.2. HOSPITALS

7.2.1. Global IVF hospitals end-user market by Region

7.3. SURGICAL CENTERS

7.3.1. Global IVF surgical centers end-user market by region

7.4. CLINICAL RESEARCH INSTITUTES

7.4.1. Global IVF clinical research institutes end-user market by region

7.5. CLINICS

7.5.1. Global IVF Clinics end-users market by region

Chapter: 8 IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY

8.1. NORTH AMERICA

8.1.1. North America IVF Devices and Consumables Market, By components
8.1.2. U.S. IVF devices and consumables market
8.1.3. Canada IVF devices and consumables market
8.1.4. Mexico IVF devices and consumables market

8.2. EUROPE

8.2.1. Europe IVF Devices and Consumables Market, By Component
8.2.2. Germany IVF devices and consumables market
8.2.3. France IVF devices and consumables market
8.2.4. UK IVF devices and consumables market
8.2.5. Other Europe IVF devices and consumables market

8.3. ASIA-PACIFIC

8.3.1. Asia-Pacific IVF Devices and Consumables Market, By Component
8.3.2. India IVF devices and consumables market
8.3.3. China IVF devices and consumables market
8.3.4. Japan IVF devices and consumables market
8.3.5. Australia IVF devices and consumables market
8.3.6. Other Asia-Pacific IVF devices and consumables market

8.4. LAMEA

8.4.1. LAMEA IVF Devices and Consumables Market, By Component
8.4.2. Latin America IVF devices and consumables market

8.4.2.1. Brazil IVF devices and consumables market

8.4.3. Middle East IVF devices and consumables market
8.4.4. Africa IVF devices and consumables market

Chapter: 9 COMPANY PROFILE

9.1. COOK MEDICAL, INC.

9.1.1. Company overview
9.1.2. SWOT analysis of Cook Medical, Inc.

9.2. COOPER COMPANIES, INC. (COOPER SURGICAL, INC.)

9.2.1. Company overview
9.2.2. Business performance
9.2.3. Strategic moves and developments
9.2.4. SWOT analysis of Cooper Surgical, Inc.

9.3. GENEA BIOMEDX

9.3.1. Company overview
9.3.2. Strategic moves and developments
9.3.3. SWOT analysis of Genea Biomedx

9.4. JXTG HOLDINGS, INC.

9.4.1. Company overview
9.4.2. Business performance
9.4.3. Strategic moves and developments
9.4.4. SWOT analysis of JX Holdings

9.5. MERCK KGAA (EMD SERONO, INC.)

9.5.1. Company overview
9.5.2. Business performance
9.5.3. Strategic moves and developments
9.5.4. SWOT analysis of Merck KGaA

9.6. OVASCIENCE INC.

9.6.1. Company overview
9.6.2. Business performance
9.6.3. Strategic moves and developments
9.6.4. SWOT analysis of OvaScience, Inc.

9.7. OXFORD GENE TECHNOLOGY

9.7.1. Company overview
9.7.2. Strategic moves and developments
9.7.3. SWOT analysis of Oxford Gene Technology

9.8. PROGYNY, INC.

9.8.1. Company overview
9.8.2. Strategic moves and developments
9.8.3. SWOT analysis of Progyny, Inc.

9.9. THERMO FISHER SCIENTIFIC INC.

9.9.1. Company overview
9.9.2. Business performance
9.9.3. Strategic moves and developments
9.9.4. SWOT analysis of Thermo Fisher Scientific, Inc.

9.10. VITROLIFE AB

9.10.1. Company overview
9.10.2. Business performance
9.10.3. Strategic moves and developments
9.10.4. SWOT analysis of Vitrolife AB

LIST OF TABLES

TABLE 1. COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2. COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3. COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4. COST OF DONOR EGG PROCEDURE IN U.S. (2014)
TABLE 5. COST OF SPERM DONATION (2014)
TABLE 6. AVERAGE SURROGACY COSTS, 2014
TABLE 7. COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8. COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9. APPLICATIONS OF PGD TECHNOLOGY
TABLE 10. PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 11. AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 12. COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2014-2017
TABLE 13. INSURANCE COVERAGE FOR COUNTRIES
TABLE 14. INFERTILITY RATES IN NORTH AMERICA
TABLE 15. GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16. IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENTS TYPES, 2014-2023 ($MILLION)
TABLE 18. TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19. GLOBAL IVF INCUBATORS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 20. GLOBAL IVF CRYOSYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 21. GLOBAL IVF IMAGING SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 22. GLOBAL IVF CABINETS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 23. GLOBAL IVF OVUM ASPIRATION PUMP MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 24. MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25. GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 26. GLOBAL IVF MICROMANIPULATOR MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 27. GLOBAL IVF OTHER INSTRUMENTS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 28. GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 29. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2023 ($MILLION)
TABLE 30. ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31. CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32. GLOBAL IVF CRYOPRESERVATION MEDIA MARKET, BY REGION, 2014-2023 ($MILLION)
TABLE 33. COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34. GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 35. GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 36. EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37. GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 38. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2023 ($MILLION)
TABLE 39. GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 40. COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41. GLOBAL FROZEN EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 42. GLOBAL DONOR EGG IVF CYCLE MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 43. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2023 ($MILLION)
TABLE 44. GLOBAL IVF HOSPITALS END USER MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 45. GLOBAL IVF SURGICAL CENTERS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 46. GLOBAL IVF CLINICAL RESEARCH INSTITUTES END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 47. GLOBAL IVF CLINICS END USERS MARKET BY REGION, 2014-2023 ($MILLION)
TABLE 48. GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 2014-2023 ($MILLION)
TABLE 49. REGULATORY SCENARIO, NORTH AMERICA
TABLE 50. NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 51. EUROPE IVF CYCLES IN 2014
TABLE 52. REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53. REGULATORY SCENARIO, EUROPE
TABLE 54. EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 55. POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56. ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 57. TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58. REGULATORY SCENARIO, LAMEA
TABLE 59. LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014-2023 ($MILLION)
TABLE 60. BRAZIL IVF DEVICES AND CONSUMABLES MARKET, 2014-2023 ($MILLION)
TABLE 61. COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 62. COOPER COMPANIES, INC. BUSINESS SNAPSHOT
TABLE 63. GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 64. JX HOLDINGS BUSINESS SNAPSHOT
TABLE 65. MERCK KGAA BUSINESS SNAPSHOT
TABLE 66. OVASCIENCE, INC. BUSINESS SNAPSHOT
TABLE 67. OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 68. PROGYNY, INC. BUSINESS SNAPSHOT
TABLE 69. THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 70. VITROLIFE AB BUSINESS SNAPSHOT

LIST OF FIGURES

FIGURE 1. IVF DEVICES MARKET DEFINITION
FIGURE 2. ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIGURE 3. TOP IMPACTING FACTORS (2014-2020)
FIGURE 4. TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES MARKET (2014-2023)
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION
FIGURE 6. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET (NATURE AND COMPANY), 2014-2017
FIGURE 7. TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKE (NATURE AND TYPE), 2014-2017
FIGURE 8. PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIGURE 10. PATENT ANALYSIS BY YEAR (2011-2016)
FIGURE 11. PATENT ANALYSIS BY GEOGRAPHY (2011-2016)
FIGURE 12. EFFECT OF AGE ON FERTILITY
FIGURE 13. COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIGURE 14. SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, U.S.
FIGURE 15. PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, (U.S.)
FIGURE 16. SWOT ANALYSIS OF COOK MEDICAL, INC.
FIGURE 17. COOPER COMPANIES, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 18. COOPER COMPANIES, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 19. COOPER COMPANIES, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 20. SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIGURE 21. SWOT ANALYSIS OF GENEA BIOMEDX
FIGURE 22. JX HOLDINGS FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 23. JX HOLDINGS FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 24. JX HOLDINGS FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 25. SWOT ANALYSIS OF JX HOLDINGS
FIGURE 26. MERCK KGAA FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 27. MERCK KGAA FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 28. MERCK KGAA FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 29. SWOT ANALYSIS OF MERCK KGAA
FIGURE 30. OVASCIENCE, INC. REVENUE, 2015-2016 ($MILLION)
FIGURE 31. SWOT ANALYSIS OF OVASCIENCE, INC.
FIGURE 32. SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIGURE 33. SWOT ANALYSIS OF PROGYNY, INC.
FIGURE 34. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 36. THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 37. SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIGURE 38. VITROLIFE INC. FINANCIAL REVENUE BY YEAR, 2014-2016 ($MILLION)
FIGURE 39. VITROLIFE INC. FINANCIAL REVENUE BY BUSINESS UNIT, 2016
FIGURE 40. VITROLIFE INC., FINANCIAL REVENUE BY GEOGRAPHY, 2016
FIGURE 41. SWOT ANALYSIS OF VITROLIFE AB

 

In vitro fertilization (IVF) stands for fertilization of the male and female gametes that form the human embryo outside the womb-in a petri-dish in laboratory settings. This embryo is then transferred to the uterus for gestation. It is one of the most popular assisted reproductive technologies (ART) for successful fertilization. IVF treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention

The IVF devices and consumables market is anticipated to witness considerable growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, increase in awareness regarding in vitro fertilization, surge in popularity of medical & fertility tourism, and advanced IVF facilities & treatment options are anticipated to supplement the market growth.

However, inadequate reimbursement policies associated with IVF treatment are anticipated to impede the market growth during the forecast period. Moreover, growth in interest of single parents as well as same sex couples in experiencing parenthood through artificial reproductive technology (ART), especially IVF, is expected to present lucrative opportunities for market expansion. At present, the fertility clinics are the largest end users of IVF treatment, followed by hospitals, surgical centers, and clinical research institutes. The surgical center end user segment is expected to exhibit the highest growth rate throughout the forecast period.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, For any queries, please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASK
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts